Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-033393

Chairman & CEO acquired 100,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHADE CHRISTIAN S Chairman & CEO 2022-03-10 Grant or award +100,100 255,116 D
Derivatives
SCHADE CHRISTIAN S Chairman & CEO 2022-03-10 Grant or award · Stock Option (right to Buy) +427,700 427,700 D
Loading xslF345X03/tm229119-5_4seq1.xml…